Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Selective infection of antigen-specific B lymphocytes by Salmonella mediates bacterial survival and systemic spreading of infection.

Souwer Y, Griekspoor A, de Wit J, Martinoli C, Zagato E, Janssen H, Jorritsma T, Bar-Ephraïm YE, Rescigno M, Neefjes J, van Ham SM.

PLoS One. 2012;7(11):e50667. doi: 10.1371/journal.pone.0050667. Epub 2012 Nov 29.

2.

The development and psychometric properties of the Humanitarian Emergency Settings Perceived Needs (HESPER) Scale.

Semrau M, van Ommeren M, Blagescu M, Griekspoor A, Howard LM, Jordans M, Lempp H, Marini A, Pedersen J, Pilotte I, Slade M, Thornicroft G.

Am J Public Health. 2012 Oct;102(10):e55-63. Epub 2012 Aug 16.

3.

B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production.

Souwer Y, Griekspoor A, Jorritsma T, de Wit J, Janssen H, Neefjes J, van Ham SM.

J Immunol. 2009 Jun 15;182(12):7473-81. doi: 10.4049/jimmunol.0802831.

4.

A high-tech infusion for science.

Griekspoor A.

Dis Model Mech. 2008 Sep-Oct;1(2-3):87-8. doi: 10.1242/dmm.001297. No abstract available.

5.

Cryo-immunogold electron microscopy.

Peters PJ, Bos E, Griekspoor A.

Curr Protoc Cell Biol. 2006 Apr;Chapter 4:Unit 4.7. doi: 10.1002/0471143030.cb0407s30.

PMID:
18228493
6.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R.

Adv Exp Med Biol. 2007;604:17-46.

PMID:
17695719
7.

PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1.

Zwart W, Griekspoor A, Berno V, Lakeman K, Jalink K, Mancini M, Neefjes J, Michalides R.

EMBO J. 2007 Aug 8;26(15):3534-44. Epub 2007 Jul 12.

8.

Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alpha.

Zwart W, Griekspoor A, Rondaij M, Verwoerd D, Neefjes J, Michalides R.

Mol Cancer Ther. 2007 May;6(5):1526-33.

9.

Visualizing the action of steroid hormone receptors in living cells.

Griekspoor A, Zwart W, Neefjes J, Michalides R.

Nucl Recept Signal. 2007 Mar 9;5:e003. Review.

10.

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ.

J Exp Med. 2006 May 15;203(5):1259-71. Epub 2006 Apr 24.

11.

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R.

Cell. 2006 Mar 24;124(6):1169-81.

12.

MHC class I alleles and their exploration of the antigen-processing machinery.

Groothuis TA, Griekspoor AC, Neijssen JJ, Herberts CA, Neefjes JJ.

Immunol Rev. 2005 Oct;207:60-76. Review.

PMID:
16181327
13.

Presenting antigen presentation in living cells using biophysical techniques.

Griekspoor A, Zwart W, Neefjes J.

Curr Opin Microbiol. 2005 Jun;8(3):338-43. Review.

PMID:
15939359
14.

Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis.

Marsman M, Jordens I, Griekspoor A, Neefjes J.

Adv Cancer Res. 2005;93:129-58. Review.

PMID:
15797446
15.

Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.

Zwart W, Griekspoor A, Kuijl C, Marsman M, van Rheenen J, Janssen H, Calafat J, van Ham M, Janssen L, van Lith M, Jalink K, Neefjes J.

Immunity. 2005 Feb;22(2):221-33.

16.

Change will not happen overnight.

Griekspoor A, Nabarro D, Loretti A, Smith I.

BMJ. 2005 Jan 29;330(7485):250-1. No abstract available.

17.

The health sector gap in the southern Africa crisis in 2002/2003.

Griekspoor A, Spiegel P, Aldis W, Harvey P.

Disasters. 2004 Dec;28(4):388-404. Erratum in: Disasters. 2005 Mar;29(1):following table of contents.

PMID:
15569380
18.

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

Michalides R, Griekspoor A, Balkenende A, Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L, Neefjes J.

Cancer Cell. 2004 Jun;5(6):597-605.

19.

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, Janssen H, Calafat J, Drijfhout JW, Neefjes J.

Immunity. 2003 Jan;18(1):97-108.

20.

Herpes viral proteins manipulating the peptide transporter TAP.

Reits E, Griekspoor A, Neefjes J.

Curr Top Microbiol Immunol. 2002;269:75-83.

PMID:
12224517
21.

Enhancing the quality of humanitarian assistance: taking stock and future initiatives.

Griekspoor A, Sondorp E.

Prehosp Disaster Med. 2001 Oct-Dec;16(4):209-15.

PMID:
12090200
22.

Health and peace: an opportunity to join forces.

Griekspoor A, Loretti A.

Lancet. 2001 Oct 6;358(9288):1183; author reply 1184. No abstract available.

PMID:
11597705
23.

Raising standards in emergency relief: how useful are Sphere minimum standards for humanitarian assistance?

Griekspoor A, Collins S.

BMJ. 2001 Sep 29;323(7315):740-2. No abstract available.

24.

Refugees.

Griekspoor A, Loretti A.

Lancet. 2001 Sep 8;358(9284):845. No abstract available.

PMID:
11570413
25.

Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body.

van Lith M, van Ham M, Griekspoor A, Tjin E, Verwoerd D, Calafat J, Janssen H, Reits E, Pastoors L, Neefjes J.

J Immunol. 2001 Jul 15;167(2):884-92.

26.

How does TAP pump peptides? insights from DNA repair and traffic ATPases.

Reits EA, Griekspoor AC, Neefjes J.

Immunol Today. 2000 Dec;21(12):598-600. Review. No abstract available.

PMID:
11114418
27.

What to do with HLA-DO?

van Ham M, van Lith M, Griekspoor A, Neefjes J.

Immunogenetics. 2000 Aug;51(10):765-70. Review.

PMID:
10970090
28.

Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.

Griekspoor A, Sondorp E, Vos T.

Health Policy Plan. 1999 Mar;14(1):70-6.

PMID:
10351471
29.

[Physicians without borders and diarrhea as a cause of illness and death in refugee camps].

Meijman HJ, Blok ML, Griekspoor A.

Ned Tijdschr Geneeskd. 1996 Aug 10;140(32):1658-62. Dutch. No abstract available.

PMID:
8815408
30.

[What was Doctors without Borders doing in Albania?].

Meijman HJ, Veeken H, Griekspoor A.

Ned Tijdschr Geneeskd. 1996 Feb 17;140(7):377-80. Dutch. No abstract available.

PMID:
8628426

Supplemental Content

Loading ...
Support Center